ADUS:NGS-Addus HomeCare Corporation (USD)

EQUITY | Medical Care Facilities | Nasdaq Global Select

Last Closing

USD 131.4

Change

0.00 (0.00)%

Market Cap

USD 0.39B

Volume

0.47M

Analyst Target

USD 119.88
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Addus HomeCare Corp provides home and community based services, which are social in nature and are provided in the home, focused on the dual eligible population.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-22 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

-0.74 (-0.55%)

USD 8.25B
OPCH Option Care Health Inc

+0.01 (+0.04%)

USD 4.00B
ACHC Acadia Healthcare Company Inc

-0.40 (-1.06%)

USD 3.78B
AMED Amedisys Inc

+0.60 (+0.71%)

USD 2.81B
LFST Lifestance Health Group Inc

-0.03 (-0.41%)

USD 2.74B
SGRY Surgery Partners Inc

-0.12 (-0.57%)

USD 2.59B
ASTH Astrana Health Inc

-0.23 (-0.68%)

USD 1.89B
AVAH Aveanna Healthcare Holdings In..

-0.10 (-2.18%)

USD 1.04B
HCSG Healthcare Services Group Inc

-0.18 (-1.59%)

USD 0.91B
CCRN Cross Country Healthcare Inc

-0.01 (-0.06%)

USD 0.58B

ETFs Containing ADUS

SBM 7.23 % 0.95 %

N/A

N/A
SMN ProShares UltraShort Basi.. 7.23 % 0.95 %

-0.28 (0.23%)

N/A
BASE-B:CA Evolve Global Materials &.. 5.10 % 0.00 %

+0.21 (+0.23%)

CAD 0.08B
JHMA 4.37 % 0.47 %

N/A

N/A
ABEQ Absolute Core Strategy ET.. 4.11 % 0.00 %

+0.07 (+0.23%)

USD 0.09B
XLPE:LSE Xtrackers LPX Private Equ.. 3.49 % 0.00 %

-4.00 (0.23%)

N/A
IUMS:LSE iShares S&P 500 Materials.. 3.37 % 0.00 %

-0.10 (0.23%)

USD 0.18B
IMSU:LSE iShares S&P 500 Materials.. 3.33 % 0.00 %

-3.50 (0.23%)

N/A
UYM ProShares Ultra Basic Mat.. 2.97 % 0.95 %

+0.04 (+0.23%)

N/A
MXI iShares Global Materials .. 1.46 % 0.46 %

+0.27 (+0.23%)

N/A
VVAL:LSE 0.54 % 0.00 %

N/A

N/A
VCIT Vanguard Intermediate-Ter.. 0.10 % 0.07 %

-0.20 (0.23%)

USD 49.51B
SCHJ Schwab 1-5 Year Corporate.. 0.09 % 0.00 %

-0.01 (0.23%)

N/A
VCSH Vanguard Short-Term Corpo.. 0.08 % 0.07 %

-0.05 (0.23%)

USD 35.42B
VCLT Vanguard Long-Term Corpor.. 0.07 % 0.07 %

-0.36 (0.23%)

USD 15.44B
BIV Vanguard Intermediate-Ter.. 0.05 % 0.07 %

-0.23 (0.23%)

N/A
BLV Vanguard Long-Term Bond I.. 0.04 % 0.07 %

-0.38 (0.23%)

N/A
BSV Vanguard Short-Term Bond .. 0.02 % 0.07 %

-0.10 (0.23%)

N/A
FMAT Fidelity® MSCI Materials.. 0.00 % 0.08 %

-0.01 (0.23%)

N/A
SPVM Invesco S&P 500 Value wit.. 0.00 % 0.39 %

-0.21 (0.23%)

USD 0.09B
VAW Vanguard Materials Index .. 0.00 % 0.10 %

-0.21 (0.23%)

N/A
WMCR 0.00 % 0.50 %

N/A

N/A
SXLB:LSE SPDR S&P U.S. Materials S.. 0.00 % 0.00 %

-0.39 (0.23%)

N/A
SCHI Schwab 5-10 Year Corporat.. 0.00 % 0.00 %

-0.06 (0.23%)

USD 7.69B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 41.52% 93% A 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 41.52% 93% A 84% B
Trailing 12 Months  
Capital Gain 36.38% 93% A 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 36.38% 93% A 82% B
Trailing 5 Years  
Capital Gain 39.00% 70% C- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.00% 70% C- 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 7.70% 56% F 57% F
Dividend Return 7.70% 56% F 55% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 24.27% 89% A- 71% C-
Risk Adjusted Return 31.73% 70% C- 63% D
Market Capitalization 0.39B 76% C+ 80% B-

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 49.30 59% 35%
Price/Book Ratio 2.33 46% 45%
Price / Cash Flow Ratio 20.19 28% 16%
Price/Free Cash Flow Ratio 16.85 38% 23%
Management Effectiveness  
Return on Equity 9.03% 78% 75%
Return on Invested Capital 9.04% 79% 76%
Return on Assets 6.27% 89% 89%
Debt to Equity Ratio 17.57% 63% 63%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.